Rational medication in clinical practice for COVID-19 guided by Shanghai expert consensus / 中华临床感染病杂志
Chinese Journal of Clinical Infectious Diseases
; (6): 7-12, 2021.
Article
em Zh
| WPRIM
| ID: wpr-884828
Biblioteca responsável:
WPRO
ABSTRACT
The outbreak of COVID-19 occurred in January 2020, the epidemic is still rampant around the world. The Shanghai Expert Consensus on Comprehensive Treatment and Management of Corona Virus Disease 2019 was issued in early March 2020, which provided the guidance of the standardized treatment and rational medication for COVID-19. The administration of " four agents (glucocorticoids, heparin, high-dose vitamin C, Interferon-κ) and one peptide (thymic peptide)" recommended by the consensus is the key to successfully block and treat critical illness.
Texto completo:
1
Base de dados:
WPRIM
Tipo de estudo:
Guideline
Idioma:
Zh
Revista:
Chinese Journal of Clinical Infectious Diseases
Ano de publicação:
2021
Tipo de documento:
Article